Table 2.
Characteristics of the included studies.
| Study, Year [Reference] | Sample size | Intervention | Outcome indicators | |||
|---|---|---|---|---|---|---|
| Acu | Control | Acu | Control | Acupoints selection | ||
| Gao and Zhong (16) | 30 | 30 | Electro | Routine | LI14, LI15, etc | ② |
| Huang et al. (17) | 62 | 62 | Facial + Prednisone | Prednisone | Shoulder poin, Elbow point, Upper Burner | ③ |
| Wang et al. (18) | 46 | 46 | Wrist-ankle | Routine | Upper 4, 5, 6 zone of the affected side | ②④ |
| Xie et al. (19) | 30 | 30 | Electro + Myoelectricity | Myoelectricity | SI9, LI14, LI15, GB21 | ②④ |
| Xing et al. (20) | 35 | 37 | Wrist-ankle | Routine | Upper 4, 5, 6 zone of the affected side | ②④ |
| Hong and Lei (21) | 35 | 35 | Millimetre | Routine | BL64,SI9,SI3,SJ14,LI15, etc | ①② |
| Shi (22) | 33 | 32 | Warm | Routine | LI14, LI15, SI9 | ①③ |
| Duan et al. (23) | 46 | 46 | Electro | Routine | LI15, LI14, SJ14 | ①②③④ |
| Huang et al. (24) | 30 | 30 | Warm | Routine | LI15, SI9, LI14 | ② |
| Gao et al. (25) | 32 | 32 | Superficial | Routine | Myofascial lines | ② |
| Qian and Shou (26) | 40 | 40 | Wrist-ankle | Routine | Upper 4, 5 zone of the affected side | ②③ |
| Xiong et al. (27) | 30 | 30 | Wrist-ankle + Dizocin | Dizocin | Upper 2, 4, 5 zone of the affected side | ②③ |
| Zhang (28) | 38 | 37 | Millimetre | Routine | SI9, SJ14, LI15 | ①②④ |
| Wang and Liu (29) | 30 | 30 | Millimetre | Routine | LI15, SJ14, LI14, GB21 | ② |
| Ning et al. (30) | 30 | 30 | Electro | Routine | LI15, LI14, SJ14 | ②③ |
| Wang et al. (31) | 40 | 40 | Electro | Routine | SI9, SJ14, LI15, SI11, LI14 | ②④ |
| Zhang et al. (32) | 35 | 35 | Warm | Routine | LI14, LI15, SI9 | ③ |
| Cai (33) | 30 | 30 | Warm | Routine | LI14, LI15, SI9 | ②③ |
①: effective rate; ②: VAS scores; ③: CMS scores; ④: shoulder mobility; Acupoints selection is according to the WHO international standard terminologies.